STAT — Reporting from the frontiers of health and medicine
- Health Some hoped a new oral vaccine would solve all the polio campaign’s problems. Reality is settling in
- Pharmalot STAT Plus: Gilead and Teva defend antitrust claims that prices for HIV medicines were unfairly kept high
- Exclusive STAT Plus: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals
- Business STAT Plus: U.K. unveils $800 million package to bolster life sciences amid concern over biopharma investments
- Pharma STAT Plus: Bristol drug reduces reliance on transfusions for people with chronic blood disorder
- The Readout LOUD Listen: ChatGPT in medicine, a boom in weight loss pills, & Sarepta at the FDA
- Biotech STAT Plus: Illumina shareholders elect one Icahn ally to board, as company holds off broader challenge
- Health Some hoped a new oral vaccine would solve all the polio campaign’s problems. Reality is settling in
- Pharmalot STAT Plus: Gilead and Teva defend antitrust claims that prices for HIV medicines were unfairly kept high
- Exclusive STAT Plus: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals
- Business STAT Plus: U.K. unveils $800 million package to bolster life sciences amid concern over biopharma investments
- Pharma STAT Plus: Bristol drug reduces reliance on transfusions for people with chronic blood disorder
- The Readout LOUD Listen: ChatGPT in medicine, a boom in weight loss pills, & Sarepta at the FDA
- Biotech STAT Plus: Illumina shareholders elect one Icahn ally to board, as company holds off broader challenge
-
STAT Plus: Boston Scientific cancels $230 million deal to buy Korean device company
-
STAT Plus: Seagen criticized by shareholder advisory firm for ‘problematic’ executive compensation ahead of Pfizer acquisition
-
STAT Plus: Supreme Court rules against Amgen in closely watched case over scope of patent claims
advertisement
- Health Tech STAT Plus: What does generative AI mean for health care? We asked the experts
- Health STAT Plus: Addiction treatment center founder indicted in sprawling fraud scheme
- Health Science finally figured out how to make effective RSV vaccines. Will seniors care?
-
- Exclusive STAT Plus: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals
- First Opinion STAT Plus: An overlooked way to make participants in clinical trials look more like America
- First Opinion How Tennessee is creating new opportunities for doctors trained outside the U.S.
- In the Lab STAT Plus: Immunotherapy turned brain cancers from ‘cold’ to ‘hot’ in mouse study, as clinical trials advance
- Health Texas wants to wean trans youth off meds in a ‘safe and medically appropriate’ way. Doctors say that’s impossible
- Biotech STAT Plus: Illumina shareholders elect one Icahn ally to board, as company holds off broader challenge
Reporter Spotlight
Ambar Castillo is a 2022-2023 Sharon Begley Science Reporting Fellow at STAT.
Nicholas Florko reports on the commercial determinants of health.
Brittany Trang is a 2022-2023 Sharon Begley Science Reporting Fellow at STAT.
